Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024年2月21日 - 6:22AM
Edgar (US Regulatory)
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of February 2024
Commission File Number: 001-11960
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
United Kingdom
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether the registrant by
furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes
¨
No x
If “Yes” is marked, indicate below
the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82-_____________
Exhibit Index
ANNUAL FINANCIAL REPORT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: 20 February 2024
|
By: |
/s/ Adrian Kemp |
|
Name: Adrian Kemp |
|
Title: Company Secretary |
AstraZeneca (PK) (USOTC:AZNCF)
過去 株価チャート
から 4 2024 まで 5 2024
AstraZeneca (PK) (USOTC:AZNCF)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about AstraZeneca Plc (PK) (その他OTC): 0 recent articles
その他のAstraZeneca Plc (PK)ニュース記事